← Insider buys
ALLO

Allogene Therapeutics, Inc. · Healthcare

EVP of R, D, CMO Rafael Amado sold $355K of Allogene Therapeutics, Inc.

Sold$354,662
$36.37Price
9,752Shares
−7%Stake

What ALLO did after the filing

Prices for ALLO after this filing aren't in yet.

Traded Thu, Oct 1. Filed Fri, Oct 2, 4:40 PM ET, after the close. Not investment advice.